[
    [
        {
            "time": "2018-07-17",
            "original_text": "华大基因股价三折甩卖无人理",
            "features": {
                "keywords": [
                    "华大基因",
                    "股价",
                    "三折",
                    "甩卖",
                    "无人理"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "华大基因股价三折甩卖无人理",
                "Correlation": 9,
                "Sentiment": 2,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-07-17",
            "original_text": "负面缠身的华大基因连续跌停 巨量解禁后机构将如何抽身？",
            "features": {
                "keywords": [
                    "华大基因",
                    "负面",
                    "连续跌停",
                    "巨量解禁",
                    "机构"
                ],
                "sentiment_score": -0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "负面缠身的华大基因连续跌停 巨量解禁后机构将如何抽身？",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 10,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-07-17",
            "original_text": "华大基因两跌停后7高管出手：3000万增持拟对冲百亿限售解禁",
            "features": {
                "keywords": [
                    "华大基因",
                    "两跌停",
                    "高管",
                    "增持",
                    "限售解禁"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华大基因两跌停后7高管出手：3000万增持拟对冲百亿限售解禁",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-07-17",
            "original_text": "华大基因与举报方名誉权案中止审理",
            "features": {
                "keywords": [
                    "华大基因",
                    "举报",
                    "名誉权",
                    "中止审理"
                ],
                "sentiment_score": 0.2,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "华大基因与举报方名誉权案中止审理",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-07-17",
            "original_text": "17日晚公告精编丨华大基因连续2日一字跌停，公司高管拟增持",
            "features": {
                "keywords": [
                    "华大基因",
                    "一字跌停",
                    "高管",
                    "增持"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "17日晚公告精编丨华大基因连续2日一字跌停，公司高管拟增持",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-07-17",
            "original_text": "连续两日跌停 华大基因部分董事高管拟增持股份",
            "features": {
                "keywords": [
                    "华大基因",
                    "连续两日跌停",
                    "董事",
                    "高管",
                    "增持"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "连续两日跌停 华大基因部分董事高管拟增持股份",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-07-17",
            "original_text": "华大基因连续2日一字跌停 公司高管拟增持3000万",
            "features": {
                "keywords": [
                    "华大基因",
                    "一字跌停",
                    "高管",
                    "增持",
                    "3000万"
                ],
                "sentiment_score": -0.65,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "华大基因连续2日一字跌停 公司高管拟增持3000万",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-07-17",
            "original_text": "华大基因：部分董事、高管计划增持不低于3000万元",
            "features": {
                "keywords": [
                    "华大基因",
                    "董事",
                    "高管",
                    "增持",
                    "3000万元"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华大基因：部分董事、高管计划增持不低于3000万元",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-07-17",
            "original_text": "【解盘论市】创业板积极向上八连阳，嫣然一笑走向前方",
            "features": {
                "keywords": [
                    "创业板",
                    "八连阳",
                    "积极向上"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "创业板"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【解盘论市】创业板积极向上八连阳，嫣然一笑走向前方",
                "Correlation": 2,
                "Sentiment": 7,
                "Importance": 5,
                "Impact": 3,
                "Duration": 5,
                "Entity_Density": 1,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-07-17",
            "original_text": "大盘探底回升 长下影线背后有何玄机？——道达投资手记",
            "features": {
                "keywords": [
                    "大盘",
                    "探底回升",
                    "长下影线",
                    "道达投资手记"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "大盘"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "大盘探底回升 长下影线背后有何玄机？——道达投资手记",
                "Correlation": 1,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 3,
                "Duration": 4,
                "Entity_Density": 1,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]